Yann Mazabraud joined Rhythm as Executive Vice President, Head of International, in October 2020. Yann brings more than two decades of experience leading rare disease global commercial strategy, market access and marketing. He joined the Company from Trevi Therapeutics, where he served as Chief Commercial Officer and Head of International for two years. Prior to that, he held several leadership positions at Sanofi Genzyme, including, Head of Latin America, U.S. General Manager and North America Head, Rare Diseases. He also served as a member of the Sanofi Genzyme Executive Leadership Team. While at Genzyme and Sanofi Genzyme, he led and managed several product launches for rare genetic diseases in Europe, Latin America and the United States across multiple areas including genetics, pediatrics, nephrology, neurology and endocrinology. Yann holds a master’s degree in management from Ecole Supérieure de Commerce de La Rochelle.
Senior Management
-
David Meeker, MD
Chairman, President
and Chief Executive Officer -
Jennifer Chien
Executive Vice President,
Head of North America -
Simon D. Kelner
Chief Human Resources
Officer -
Yann Mazabraud
Executive Vice President,
Head of International -
Hunter Smith
Chief Financial
Officer -
Murray Stewart, MD
Chief Medical
Officer -
Satej Bhandarkar
Senior Vice-President, Program Management, Strategy and Corporate Development -
Jim Flaherty
Senior Vice President
and General Counsel -
Alastair Garfield
Vice President,
Head of Research -
Joe Shulman
Senior Vice President,
Technical Operations -
Irene Aquino
Vice President, Patient Engagement
Advocacy and Support -
Brieana Buckley
Vice President,
Medical Affairs -
Gregory Gordon
Vice President,
Clinical -
Joanne E. Totosy de Zepetnek
Vice President,
Regulatory Affairs and Quality